Tissue engineering company Organovo Holdings scorched higher by 28% in April on the heels of a preliminary fourth-quarter earnings release. Was the data really as good as the stock move implies?
Tissue engineering company Organovo Holdings scorched higher by 28% in April on the heels of a preliminary fourth-quarter earnings release. Was the data really as good as the stock move implies?